Please note: a valid prescription is required for all prescription medication.
Myfortic® Delayed-Release Tablets for Kidney Transplant Patients
Stock up and Save - Get 20% off when you buy 3 or more of any one product. Use code SAVE20 at checkout.
Coupon code cannot be combined with other offers. Sale applies to all products originating from Canada. Maximum allowable quantity equal to a 90 day supply per single order.
$508.99
Secure Encrypted Payments
Mycophenolic acid is an immunosuppressant used after kidney transplant to help prevent rejection. This page explains how the delayed-release tablets work, who they suit, and how to use them with your prescription. We offer US shipping from Canada for Mycophenolic Acid 360mg without insurance.
What Myfortic Is and How It Works
Myfortic® contains mycophenolate sodium, which converts to mycophenolic acid in the body. It inhibits inosine monophosphate dehydrogenase (IMPDH), limiting T- and B-lymphocyte proliferation. The delayed-release design helps release medicine in the small intestine, which may improve gastrointestinal tolerability compared with immediate-release forms. YouDrugstore is a licensed Canadian pharmacy in Manitoba. Pharmacists review prescriptions before dispensing.
The class reduces immune activity so the transplanted kidney is less likely to be attacked. Tablets should be swallowed whole to maintain their enteric coating. Regimens typically include corticosteroids and a calcineurin inhibitor such as cyclosporine. Ask your healthcare professional to review your full transplant plan before starting.
Label information supports use of Mycophenolate sodium DR 360mg as part of a multi-drug protocol in appropriate adults. Individual dosing, monitoring, and duration are set by the prescriber, taking into account rejection risk and tolerability.
Who It’s For
This medicine is indicated to help prevent organ rejection in adults after kidney transplant. It is generally used with cyclosporine and corticosteroids. People with a history of hypersensitivity to mycophenolate or any tablet component should avoid it. Women who are pregnant or planning pregnancy should not start therapy due to embryo-fetal toxicity risk; effective contraception is required before, during, and after treatment as directed on the label.
Patients with active serious infection, severe uncontrolled gastrointestinal disease, or significant bone marrow suppression may not be candidates. Use caution in those with chronic infections or a history of skin cancer. Myfortic 360mg tablets are not for acute rejection rescue; clinicians adjust the transplant regimen if rejection is suspected.
For broader context on transplant care, see our category overview on Transplant Rejection.
Dosage and Usage
Follow the exact schedule on your prescription. Adults often take the therapy twice daily on an empty stomach, or consistently with meals if stomach upset occurs, per prescriber advice. Swallow tablets whole with water; do not crush, split, or chew. Starting therapy near the time of transplant is common under specialist supervision.
Space doses evenly to maintain stable exposure. If you also take aluminum/magnesium antacids or bile acid sequestrants, your clinician may provide timing guidance to limit absorption changes. With the regimen, periodic lab monitoring checks blood counts, kidney function, and drug safety. Always read the Medication Guide that accompanies Mycophenolic Acid 360mg tablets.
Strengths and Forms
Delayed-release, enteric-coated tablets are commonly available in:
- 180 mg delayed-release tablets
- 360 mg delayed-release tablets
Availability can vary by manufacturer and supply. Some brands are oval, film-coated, and color-distinct for each strength. Ask our team which presentations are currently in stock before you place an order. Many patients use a combination of strengths to reach the prescribed dose. A child-resistant container is typically supplied.
Some patients and prescribers reference Mycophenolic Acid 360mg delayed-release when discussing the higher strength tablet used in twice-daily regimens.
Missed Dose and Timing
If you miss a dose, take it when you remember unless it is close to the next dose. If it is almost time for the next dose, skip the missed one and resume your usual schedule. Do not double up. Try to take the medicine at the same times each day to support steady exposure. If frequent misses occur, ask your clinician or pharmacist for adherence tips or use a reminder system.
Storage and Travel Basics
Store tablets at room temperature in the original, tightly closed container. Keep the desiccant in the bottle if present, and protect from excessive moisture. Keep out of reach of children and pets. For travel, carry the labeled container and your prescription or a copy of your medication list. Use a small pill organizer only if you can keep original labeling nearby. Avoid leaving tablets in hot cars or direct sunlight.
When flying, keep the medicine in your carry-on. Security staff may ask to see the label. If your clinician provides a letter for transplant medicines, keep it with your travel documents. Our packing follows temperature-controlled handling when required.
Benefits
This therapy helps reduce the risk of immune-mediated damage to the transplanted kidney when used with a full transplant regimen. The enteric coating may improve stomach comfort for some people compared with immediate-release forms. A twice-daily schedule fits many routines. Tablet strengths allow flexible dose combinations when prescribers adjust therapy after lab review.
Side Effects and Safety
Common effects may include diarrhea, nausea, vomiting, stomach pain, headache, tremor, and swelling. Laboratory changes can include lowered white blood cells or anemia. Some patients report cough or insomnia. Because the immune system is suppressed, infections can occur more easily, including viral, bacterial, and fungal infections.
Serious risks include embryo-fetal toxicity, severe infections (including sepsis), bone marrow suppression, and possible increased risk of lymphoma or skin malignancies. Rare but serious gastrointestinal complications can occur. Report signs of infection, unusual bruising or bleeding, persistent abdominal pain, or new skin lesions to your prescriber promptly. Live vaccines should be avoided during therapy. Sunscreen and skin checks may be recommended due to malignancy risk.
For context on antifungal treatment sometimes used in immunocompromised patients, see Cresemba Uses.
Drug Interactions and Cautions
Tell your clinician and pharmacist about all medicines and supplements. Aluminum or magnesium antacids may reduce exposure. Bile acid sequestrants like cholestyramine can lower levels. Some antivirals (for example, acyclovir or ganciclovir) and other myelosuppressive agents may increase toxicity risks. Cyclosporine is standard in many regimens but can alter mycophenolic acid exposure; clinicians account for this in dosing. Oral contraceptive effectiveness may be reduced, so a reliable contraception plan is needed. Avoid live vaccines, and check that inactivated vaccines are timed appropriately.
If you are considering acid reducers, discuss choices with your prescriber or pharmacist. For information on PPIs commonly used for stomach protection, review Prevacid details with your care team.
What to Expect Over Time
You may not feel a noticeable effect day to day because the goal is immunologic control. Clinicians monitor blood counts and other labs regularly, especially early after transplant and during changes. Gastrointestinal symptoms may improve as your body adjusts, but new or worsening symptoms should be discussed. Adherence is essential; set alarms, pair doses with daily routines, and keep a small backup supply in your travel kit. Your prescriber will decide how long you stay on therapy based on graft health and overall risk.
Compare With Alternatives
Transplant regimens often combine multiple agents. Some patients use calcineurin inhibitors such as tacrolimus or cyclosporine with an antiproliferative agent like this therapy. An mTOR inhibitor such as Rapamune® may be considered in certain situations. Mycophenolate mofetil is another formulation of mycophenolic acid used in transplant protocols; your prescriber chooses the form that best fits your needs and tolerance.
When discussing options, ask about side-effect profiles, how each medicine is monitored, and how gastrointestinal tolerability compares. Always keep the transplant team informed before any switches or adjustments. Some patients may use Mycophenolic Acid 360mg generic Myfortic as directed when brand dispensing is not required.
Pricing and Access
Canadian pharmacy pricing can be competitive for transplant therapies. Check today’s listings, compare tablet strengths, and upload your prescription to see available options. We provide Mycophenolic Acid 360mg Canadian pricing with US delivery from Canada. If you are looking for deals, see our current Promotions; offers change periodically.
Create an account to streamline reorders, and add reminders so refills are on time. Our team can coordinate with your prescriber if your prescription includes refills and clarification is needed on tablet strengths. We cannot quote medical advice, but we help ensure the right product and quantity are dispensed as written.
Availability and Substitutions
Supply can vary based on manufacturer and demand. If a specific brand or strength is not available, your prescriber may recommend an equivalent strength combination or a clinically appropriate alternative. We do not substitute without prescriber authorization. For nearby options in the same therapeutic area, browse Immunology.
Patient Suitability and Cost-Saving Tips
This therapy suits adult kidney transplant recipients under specialist care. It may not be appropriate for those who are pregnant, planning pregnancy soon, or unable to complete regular lab monitoring. People with recurrent serious infections or severe gastrointestinal disease require careful evaluation.
- Multi-month fills: Ask your prescriber about longer supplies if stable.
- Aligned refills: Synchronize all transplant medicines to one refill date.
- Account reminders: Set refill alerts to avoid gaps in therapy.
- Travel backup: Carry an extra small supply and a medication list.
- Label clarity: Ensure dose and tablet strength match your plan.
Questions to Ask Your Clinician
- Initial plan: Which other transplant medicines are part of my regimen?
- Monitoring: How often will labs check blood counts and kidney function?
- Tolerability: What steps help with stomach upset or diarrhea?
- Vaccines: Which vaccines are recommended or should be avoided?
- Family planning: What contraception and timing are required around treatment?
- Interactions: How should I time antacids or bile acid sequestrants?
- Sun safety: What skin protection and checks do you recommend?
Authoritative Sources
Myfortic Manufacturer (Novartis)FDA DailyMedHealth Canada Drug Product Database
Ready to proceed? Complete your prescription order today—Ships from Canada to US with prompt, express, cold-chain shipping and temperature-controlled handling when required. This content is educational and not a substitute for professional medical advice.
Express Shipping - from $25.00
Shipping with this method takes 3-5 days
Prices:
- Dry-Packed Products $25.00
- Cold-Packed Products $35.00
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
Standard Shipping - $15.00
Shipping with this method takes 5-10 days
Prices:
- Dry-Packed Products $15.00
- Not available for Cold-Packed products
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
What’s the difference between mycophenolic acid and mycophenolate mofetil?
Both are prodrugs of mycophenolic acid, the active immunosuppressive moiety. Mycophenolate mofetil is an immediate-release form, while mycophenolate sodium uses an enteric coating for delayed release in the small intestine. Some patients find the delayed-release form easier on the stomach, though tolerability varies. Dosing and brand selection depend on your transplant team’s plan, co-therapies, and insurance coverage. Do not switch between forms unless your prescriber directs you to do so.
Can I split or crush delayed-release tablets?
No. Delayed-release tablets have an enteric coating that controls where the medicine dissolves. Splitting, crushing, or chewing can damage the coating and alter absorption, which may reduce effectiveness or increase side effects. If swallowing is difficult, speak with your clinician about options. They may adjust the regimen or suggest administration strategies that keep the coating intact while maintaining the prescribed dose schedule.
How does this medicine affect vaccines?
Immunosuppression can make vaccines less effective and increases the risk of infection from live vaccines. Live attenuated vaccines are generally avoided during therapy. Inactivated vaccines may be given, but timing is important to optimize immune response. Your transplant team typically coordinates vaccination plans before and after transplant. Always check with your prescriber before getting any shot or booster while taking this therapy.
What contraception is recommended with this treatment?
This therapy can cause embryo-fetal harm. Effective contraception is required for people who can become pregnant before starting, during treatment, and for the period recommended on the official label after stopping. Your prescriber may suggest using two complementary methods to reduce risk. If pregnancy is suspected, contact your healthcare professional immediately to discuss next steps and additional monitoring.
What monitoring will I need while taking it?
Your transplant team usually checks complete blood counts, kidney function, and sometimes drug exposure markers, especially early after transplant and during dose adjustments. They also assess for infections, gastrointestinal tolerance, and skin changes. Keep all appointments and report new symptoms promptly. Monitoring schedules vary by center and your clinical status, so follow the plan set by your prescriber.
Can I take it with antacids or stomach acid reducers?
Aluminum or magnesium antacids and bile acid sequestrants can reduce exposure to mycophenolic acid when taken at the same time. Your clinician may advise spacing them apart. Some acid-reducing therapies may be appropriate, but choices and timing should be individualized. If you need an acid reducer, ask your pharmacist or prescriber how to use it with your transplant medicines to avoid absorption issues.
What if I develop signs of infection while on therapy?
Contact your transplant team promptly if you have fever, chills, cough, painful urination, severe diarrhea, or unusual fatigue. Because this medicine lowers immune activity, infections can become serious quickly. Do not start new antibiotics or antivirals without guidance from your prescriber. They will determine if you need testing, a change in therapy, or supportive care while maintaining transplant safety.
